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Abstract
Background: Fecal microbiota transplants (FMT) are an effective treatment for patients with gut microbe dysbiosis
suffering from recurrent C. difficile infections. To further understand how FMT reconstitutes the patient’s gut commensal
microbiota, we have analyzed the colonization potential of the donor, recipient and recipient post transplant fecal
samples using transplantation in gnotobiotic mice.
Results: A total of nine samples from three human donors, recipient’s pre and post FMT were transplanted into
gnotobiotic mice. Microbiome analysis of three donor fecal samples revealed the presence of a high relative abundance
of commensal microbes from the family Bacteriodaceae and Lachnospiraceae that were almost absent in the three
recipient pre FMT fecal samples (<0.01 %). The microbe composition in gnotobiotic mice transplanted with the donor
fecal samples was similar to the human samples. The recipient samples contained Enterobacteriaceae, Lactobacillaceae,
Enterococcaceae in relative abundance of 43, 11, 8 %, respectively. However, gnotobiotic mice transplanted with the
recipient fecal samples had an average relative abundance of unclassified Clostridiales of 55 %, approximately 7000
times the abundance in the recipient fecal samples prior to transplant. Microbiome analysis of fecal samples from
the three patients early (2–4 weeks) after FMT revealed a microbe composition with the relative abundance of both
Bacteriodaceae and Lachnospiraceae that was approximately 7 % of that of the donor. In contrast, gnotobioitc mice
transplanted with the fecal samples obtained from the three at early times post FMT revealed increases in the relative
abundance of Bacteriodaceae and Lachnospiraceae microbe compositions to levels similar to the donor fecal samples.
Furthermore, the unclassified Clostridiales in the recipient samples post FMT was reduced to an average of 10 %.
Conclusion: We have used transplantation into gnotobiotic mice to evaluate the colonization potential of
microbiota in FMT patients early after transplant. The commensal microbes present at early times post FMT
out competed non-commensal microbes (e.g. such as unclassified Clostridiales) for niche space. The selective advantage
of these commensal microbes to occupy niches in the gastrointestinal tract helps to explain the success of FMT to
reconstitute the gut microbe community of patients with recurrent C. difficile infections.
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Background
Clostridium difficile infections are the major causative
agent for infective antibiotic associated diarrhea [1, 2]. In-
fections are most commonly acquired in healthcare settings
although community acquired infections are increasingly
being reported [1]. In addition to recent use of antibiotics,
other risk factors include old age, use of gastric acid
suppressing drugs and underlying chronic disease including
inflammatory bowel disease [1]. The numbers of infections
have been rising during the last decade with estimated
health care costs in the billions [3, 4].
The standard treatments for C. difficile infection con-
sist of metronidazole, vancomycin, or fidaxomicin, which
results in a rate of recurrence at about 20 %; after a third
recurrence, the risk of further episodes is even higher
[5–7]. Fecal microbiota transplantation (FMT) for treat-
ment of recurrent C. difficile has had remarkable success
rates for alleviation of the symptoms and restoration of
health [8–12].
The reason why FMT is so effective in restoring a
microbiome in the gastrointestinal tract of the patients is
unknown. Presumably, an effective long-term stable re-
construction would require the commensal microbes in
the FMT to access and occupy the niches in the gastro-
intestinal space following transplantation [13]. Although
there have been numerous reports on the composition of
the patients microbiota following FMT, there have been
no studies to examine the potential of the donor microbes
to colonize the recipients post transplant. To gain insights
into this issue, we have examined this aspect of micro-
biome reconstruction following FMT by transplanting
human fecal samples into gnotobiotic mice. Since these
mice are devoid of microbes, previous studies have shown
that the unoccupied (open) niches in the gastrointestinal
tract readily accept fecal transplantation and recapitulate
the major elements of the human microbiome in the
gnotobiotic mice [14, 15]. From the analysis of fecal
samples from gnotobiotic mice with transplanted with
donor, recipient and post FMT samples, we demonstrate
that the microbiota of recipient early post FMT possess
the capacity to reconstitute gnotobiotic mice with a
microbiome community that is similar to the donor.
Results
Three patients that had undergone fecal transplants were
chosen for this study. All of the three recipients were
positive for C. difficile at least once and had undergone
several rounds of antibiotic treatments without complete
resolution of the repeated episodes of colitis. The charac-
teristics of the recipients with respect to age, antibiotic
treatment and comorbidities in addition to the C. difficile
infection can be found in the Additional file 1: Data Set S1.
Each recipient agreed to a fecal transplant with individual
donors, usually a spouse or other family member. The
transplants were accomplished by nasogastric administra-
tion. The details for preparation of the donor sample and
administration can be found in Additional file 2: Text S1.
For all three transplants, fecal samples were collected from
donor, recipient and recipient post transplant (collected 2–
4 weeks post fecal transplant). By convention, for a given
specific transplant (e.g. transplant number 1) we refer to
the donor (D), recipient (R) and Recipient post Transplant
(RpT) with a prefix letter and the specific transplant num-
ber (e.g. D1, R1, RpT1). The Recipient post Transplant
samples also carries a suffix which represent time post
transplant i.e. RpT1w2 means that the sample is taken
2 week post fecal transplant. The human samples when
transplanted in mouse carries a prefix “M” (for example
when human sample RpT1w2 is transplanted in mouse it
is named MRpT1w2). The list of all human and mouse
samples used for microbiota analysis is presented in
Additional file 1: Data Set S1.
A total of 9 samples from three human donors, recipients
and RpT were collected and transplanted into gnotobiotic
mice each as three replicates (27 mouse samples). A total
of 36 samples were sequenced with an average sequence
depth of 95,464 reads per sample (range 58,972–172877
reads per sample). After quality filtering the sample depth
across all samples was normalized to 49,243 reads per
sample and used for analysis. A total of 469 operational
taxonomic unit (OTU) were identified.
Comparison of donor, recipient and RpT microbe
communities
Comparison of the microbe communities from recipient
and donor samples using principle coordinate analysis
(PCoA) generated from weighted UniFrac metrics revealed
each formed separate clusters (Fig. 1). The microbe com-
munities from the post FMT patients (RpT) generally clus-
tered in between the donor or recipient samples on the
PCoA plot. The donor samples showed a high abundance
of commensal microbes from the families Bacteriodaceae
(mean 25 %) and Lachnospiraceae (mean 30 %). The
Bacteriodaceae and Lachnospiraceae were almost absent
in recipient samples (<0.01 % of the abundance of the
donors). The recipient samples contained Enterobacteria-
ceae, Lactobacillaceae, Enterococcaceae in relative abun-
dance of 43, 11, 8 % respectively (these microbes were less
that 0.01 % in the donors) (Fig. 2. Additional file 3: Data
Set S2). Following FMT, the RpT samples from all three pa-
tients at 2–4 weeks showed an increase in the proportional
abundance of both Bacteriodaceae and Lachnospiraceae to
approximately 7 %. In addition, the RpT samples showed a
decrease in the abundance of families Enterobacteriaceae,
Lactobacillaceae, Enterococcaceae. The Shannon’s diversity
metric of the recipients (mean 2.63 ± 0.95) was also found
to be significantly lower than the donor population (mean
5.18 ± 0.62) (p <0.05). The RpT samples show increased
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diversity (mean 3.42 ± 0.97) when compared with the re-
cipients (Additional file 4: Data Set S3). Collectively, our
analysis demonstrates that the microbe compositions of
the donor and recipient pre FMTare clearly different. Most
importantly, the microbe composition 2–4 weeks after
FMT in the three recipients differs from both the donor
and pre FMT microbiota.
Transplant of donor and recipient pre and post FMT
microbiota into gnotobiotic mice
It has been previously shown that gnotobiotic mice
accept and recapitulate the major elements of the hu-
man microbiota after transplant [14, 15]. We wanted to
use this feature of gnotobiotic mice to examine the
colonization potential of the microbiota from the recipi-
ents prior to and after transplant. Following transplant,
the mice were housed for 4 weeks for equilibration and
the microbiome from fecal samples from each mouse
was then analyzed.
Similar to what we observed from the analysis of the
microbiome composition of the donor and recipient pre
FMT, the beta diversity comparison using PCoA plots of
the weighted UniFrac analysis showed separate clustering
of mouse transplanted donor (MD) from the mouse trans-
planted recipient (MR) (Fig. 3a). The microbiota of MD
samples was found to be statistically different (p <= 0.001)
than the MR samples. The pattern was consistent with all
three cases (Fig. 3b, c and d). The transplantation of the
fecal samples from RpT from all three of the FMT patients
into gnotobiotic mice (MRpT) resulted in a microbe com-
position in the mice that clustered with the donor (MD):
no statistical difference between MD and MRpT samples
was found (p >0.05).
The taxa analysis substantiated the microbe clustering
seen on the PCoA plots. In particular, the composition of
the MRpT from each of the samples from the mice was
similar to the composition of the MD with respect to the
abundance of the predominant families of commensal
microbiota Bacteroidaceae and Lachnospiraceae (Fig. 4). In
contrast, transplantation of the recipient samples into
gnotobiotic mice resulted in a microbe composition with
an abnormally higher proportion of unclassified Clostri-
diales (referred to as Clostridiales; Other which includes all
Clostridiales which cannot be classified at family level,
Additional file 3: Data Set 2) at an average abundance of
55 %. This relative abundance is approximately 7000 times
increased from the relative abundance in the recipient
samples (i.e. pre-transplant into gnotobiotic mice). Thus,
the microbes within the unclassified Clostridiales in the
recipients have the capacity to colonize and amplify
following transplantation into gnotobiotic mice. Further
examination of the sequences from the unclassified Clostri-
diales revealed two major OTUs. One OTU (denovo6164)
shows 100 % similarity to C. difficile (accession number
gi:822490352) while the second OTU (denovo14687)
shows 100 % similarity to Bacterium NLAE (accession
number gi:379364487). Consistent with the increased
abundance of the unclassified Clostridiales in the MR
samples, there was a lower Shannon’s diversity (2.8) as
compared to MD (4.6). The Shannon metric of diversity of
the MRpT samples was higher than that of the MR
samples and similar to that of the MD (Fig. 5).
To further highlight the commensal microbe expansion
in the gnotobiotics, we next compared the relative
abundance of the Bacteriodaceae and Lachnospiraceae in
the human and mouse transplants. The microbes of the
human donor samples demonstrated the capacity of the
Bacteriodaceae and Lachnospiraceae to colonize gnoto-
biotic mice following transplantation (Fig. 6). Even though
the RpT samples had lower abundance of Bacteriodaceae
Fig. 1 Comparison of the microbial diversity of human donors and
recipients pre and post FMT. Principal Coordinate analysis is used to
generate 3D PCoA plot (using weighted UniFrac distance metrics) for the
fecal samples from the donor (D) and recipient (R) and post FMT (RpT)
Fig. 2 Taxa distribution of human donors and recipients pre and post
transplant. A stacked bar plot depicting the taxa distribution at the
family level of the fecal samples of individual samples from the donors
and recipient pre and post FMT
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and Lachnospiraceae, the abundance of both increased
following transplant into gnotobiotic mice to a similar
abundance as gnotobiotic mice transplanted with the
donor samples, highlighting the capacity of both Bacterio-
daceae and Lachnospiraceae to effectively colonize and
even expand following transplantation (Additional file 3:
Data Set 2). In parallel, we found the relative abundance
of microbes of the unclassified Clostridiales also increased
in the MRpT from the human RpT to an average
abundance of 10 % from 0.2 % (Data Set 2). However, this
increase was only 50 times greater that that found in the
human RpT samples as compared to the 7000 times
greater for the transplant of the recipient samples in
gnotobiotic mice (i.e. human R to MR).
Fig. 3 Comparison of the microbiota community in gnotobiotic mice transplanted with fecal samples from donors, recipients pre and post transplant.
Gnotobiotic mice were transplanted with the human fecal samples from donor, recipient and RpT samples from FMT 1, 2 and 4. Panel a PCoA plot of
the fecal samples from all the gnotobiotic mice. The mice transplanted with donor, recipient, and RpT are named as MD, MR and MRpT, respectively.
The orange colored spheres are from mice transplanted with the recipient (1, 2 or 4) samples (MR), the blue spheres are from mice transplanted with
donor (1, 2 or 4) (MD) and the yellow spheres are mice transplanted with fecal samples of the FMT (MRpT). Panel b, c and d Individual PCoA plots of
donor, recipient and RpT from set 1 (Panel b), 2 (Panel c) and 4 (Pane d) transplanted into gnotobiotic mice. Each panel represents the PCoA plot of
individual mice transplanted with the donor and recipient pre and post FMT (RpT)
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Discussion
Previous studies have analyzed the microbiome of donor
and FMT recipient pre and post-transplant [16–19]. Simi-
lar to the results we found with our three patients, these
studies found that before FMT, the microbial composition
of the recipient was of low diversity and different from the
donor [16, 18–20]. Similar to our observation, Shahinas et
al. studied 2-week post-FMT samples and noted 50 %
samples show noticeable early reconstitution [17]. It is not
surprising in our study then, that early after FMT the mi-
crobe composition of the recipients was different from
both the donor and the recipient.
One of the early events for a successful transplant is
the ability of the transplanted microbiota to access the
gastrointestinal niches [21]. Once the donor microbes
reach the niches, they must also compete for nutrients
and space to expand their numbers. To gain insights
into the reconstitution of the microbial community in
the FMT patients, we took advantage of the capacity of
gnotobiotic animals since these mice are devoid of mi-
crobes and all of the niches in the gastrointestinal tract
would be open for colonization [22–24].
We first analyzed the microbe communities in mice
transplanted with the donor or recipient fecal samples.
The microbial composition of the mice transplanted with
the donor did not cluster with that of mice transplanted
with the recipients, consistent to what we saw from the
analysis of the donor and recipient obtained from humans.
Furthermore, we did not find a difference in the relative
Fig. 4 Taxa distribution of the microbial composition of mouse transplanted with donor, recipient pre and post FMT. A stacked bar plot depicting the
taxa distribution at the family level of the fecal samples of individual gnotobiotic mice transplanted with samples from the donors and recipient pre and
post FMT
Fig. 5 Shannon diversity for gnotobiotic mice transplanted with donor,
recipient pre and post FMT. Alpha diversity (Shannon’s diversity) for
gnotobiotic mice transplanted with the donor (blue), recipients pre
(orange) and post FMT (yellow) microbiota presented as a box plot
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abundance of Bacteroidaceae and Lachnospiraceae in the
human and compared to the gnotobioitic. As evidenced
from the analysis of the recipient’s microbiota, the microbe
composition was very different from that of the donor with
increased relative abundance of families Enterobacteria-
ceae, Lactobacillaceae, Enterococcaceae, consistent with a
dysbiotic microbe composition [4, 25]. Transplantation of
the recipient fecal samples into gnotobiotic mice though
revealed a different composition from that of the recipient
with an increase in the relative abundance of the unclassi-
fied Clostridiales. Thus, even though the unclassified
Clostridiales microbes represented a minor percentage of
the recipient microbes, they had the capacity to amplify
and occupy the vacant niches in the gntobiotic mice. The
reason why these microbes were not major constituents of
the recipient microbe population is unknown. One possi-
bility is that the unclassified Clostridiales might have a
selective growth advantage in the mouse gut over the other
microbes in the recipient’s sample (i.e. families Enterobac-
teriaceae, Lactobacillaceae, Enterococcaceae). Additional
experiments will be required to address this possibility.
We next characterized the colonization potential of
the recipient’s fecal sample at early times post FMT.
Even though the microbe composition 2–4 weeks after
Fig. 6 Comparison of relative abundance of selected taxa (family level). The human samples are colored in blue and the gntobiotic mice samples are
colored orange. Panel a The relative abundance of Bacteroides in the human donors and post FMT and their corresponding transplants in gnotobiotic
mice. Panel b The relative abundance of Lachnospiraceae in the human donors and post FMT and their corresponding transplant in gnotobiotic mice
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FMT in the three recipients differs from both the donor
and pre FMT microbiota, the transplantation of the RpT
fecal samples into gnotobiotic animals resulted in a
microbe composition that clustered with the donor. We
found the proportion of the commensal microbes of the
families Bacteroidaceae and Lachnospiraceae were in-
creased following transplantation into the gnotobiotic mice
to levels similar to that of the mice transplanted with the
donor samples. This result suggests that the commensal
microbes, represented by families Bacteroidaceae and
Lachnospiraceae, in the RpT transplanted into the gnoto-
biotic mice with the open niches probably out compete the
non-commensal microbes present in the sample after
FMT for niche space in the gnotobiotic mice. Support for
this conclusion comes from previous studies that have
shown commensal gut microbes such as Bacteroides, have
evolved species-specific physical interactions with the host
that mediate stable and resilient gut colonization [25–27].
One of the important functions of the commensal gut
microbes is to provide an environment to protect against
over growth of pathogenic microbes [4, 25, 28, 29]. Indeed,
the use of multiple antibiotic treatments to treat C. difficile
is thought to stress the regenerative properties of the gut
microbiota that can promote conditions conducive for over
growth of pathogens leading to the dysbiotic microbe com-
position. It was clear though from the analysis of the RpT
transplants in gnotobiotic mice that the microbes of the
families Bacteroidaceae and Lachnospiraceae had the
capacity to reconstruct a microbe community that had the
capacity to inhibit the expansion of the unclassified
Clostridiales still present in the fecal samples. In the MRpT
samples the presence of the microbes of the families Bac-
teroidaceae and Lachnospiraceae (abundance 7 % of that
found in the donor) resulted in 50 fold expansion of unclas-
sified Clostridiales as opposed to the 7000 fold expansion
on the recipient sample that had reduced amounts of the
families Bacteroidaceae and Lachnospiraceae (less that
0.01 % of the donor). It is not clear whether the reduced
expansion of the unclassified Clostridiales is due solely to
the Bacteroidaceae and Lachnospiraceae out competing for
niche space since from the studies of the recipient trans-
plants in gnotobiotic mice the unclassified Clostridiales
have the capacity to colonize the gnotobiotic mice. Another
possibility is that the mouse diet, which is known to impact
the gut microbiome composition, might have favored the
further expansion of the Bacteroidaceae and Lachnospira-
ceae over the unclassified Clostridales. Additional studies
will be needed to understand the community dynamics that
controls the continued reconstruction of the microbe com-
munity at these later times following FMT [4, 30].
Conclusion
Numerous studies have reported on the remarkable
success of FMT for treatment to resolve dysbiotic
microbiomes that are a result of extensive antibiotics to
treat C. difficile infections [4, 8–11, 16, 31, 32]. Our results
using transplantation of gnotobiotic mice as a model
demonstrates the increased colonization potential of com-
mensal microbes (families Bacteroidaceae and Lachnospir-
aceae) compared to microbes found in the dysbiotic
recipient microbiota. The increased colonization potential
of these commensal microbes for the gastrointestinal tract
provides a framework to understand the success of FMT
to reconstitute the gut microbe community of patients
with recurrent C. difficile infections.
Methods
Sample collection and processing
Fecal samples were collected from donors and recipients
prior to and post FMT. The samples were processed and
archived using 10 % glycerol as a cryopreservative as pre-
viously described [33, 34]. Consent form was obtained for
FMT and microbiome analysis as part of an ongoing Uni-
versity of Alabama at Birmingham Institutional Review
Board (UAB IRB) approved study at the University of
Alabama at Birmingham.
Isolation of microbial DNA and creation of 16S V4
amplicon library
Microbial genomic DNA was isolated using the Fecal
DNA isolation kit from Zymo Research following the
manufacturer’s instructions. Once the sample DNA was
prepared, PCR was used with unique bar coded primers
to amplify the variable region 4 (V4) region of the 16S
rDNA gene to create an amplicon library from individual
samples [33, 35] (Additional file 2: Text S1).
Illumina MiSeq DNA sequencing and bioinformatics
The PCR product was ~255 bases from the V4 segment of
the 16S rDNA gene, and we sequenced 251 bases single
end reads using Illumina MiSeq [33, 35]. FASTQ conver-
sion of the raw data files was performed following de-
multiplexing using MiSeq reporter. Quality assessment of
the FASTQ files was performed using FASTQC [36] and
then quality filtering was done using the FASTX toolkit
[37]. Due to low quality of single base toward the 3′ ends
of the read, the last base were trimmed for all reads,
making the read length as 250 bases. Any read with an
average base quality Q score of <20 and the reads with un-
known bases (“N”) were discarded. The remainder of the
steps was performed with the Quantitative Insight into
Microbial Ecology (QIIME) suite, version 1.8 as described
below [35, 38, 39]. Chimeric sequences were filtered using
the “identify_chimeric_seqs.py” module of USEARCH
[40]. Sequences were grouped into operational taxonomic
units (OTUs) using the clustering program UCLUST at a
similarity threshold of 97 % [40]. The Ribosomal Database
Program (RDP) classifier trained using the Greengenes
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(v13.8) 16S rRNA database [41] was used to make taxo-
nomic assignments for all OTUs at confidence threshold
of 80 % (0.8) [42]. The resulting OTU table included all
OTUs, their taxonomic identification, and abundance in-
formation. OTUs whose average abundance was less than
0.005 % were filtered out [43]. OTUs were then grouped
together to summarize taxon abundance at different hier-
archical levels of classification (e.g. phylum, class, order,
family, genus, and species). These taxonomy tables were
also used to generate stacked column bar charts of taxon
abundance using Microsoft Excel software (Microsoft, Se-
attle, WA). Multiple sequence alignment of OTUs was
performed with PyNAST [44]. Alpha diversity (within
sample diversity) was calculated using Shannon’s metrics
as implemented in QIIME (Additional file 4: Data Set S3)
[39]. Beta diversity (between sample diversity) among
different samples was measured using weighted Uni-
Frac metrics (distance matrices in Additional file 4:
Data Set S3) [45]. Principal coordinates analysis (PCoA)
was performed by QIIME to visualize the dissimilarity
matrix (beta-diversity) between all the samples. 3D PCoA
plots were generated using EMPEROR [46].
Statistical analysis
Samples were grouped into donor, recipient and trans-
plants for both mouse and human. Differences of taxa
abundance and alpha diversity between two groups are
measured using unpaired T-test (assuming unequal vari-
ance) and considered significant at p <0.05. Differences
in microbiota between groups are measured using PER-
MANOVA (weighted UniFrac distance).
Transplantation of archived fecal samples into
gnotobiotic mice
Germ-free C57BL/6 mice (3 mice/group) were colonized
with archived fecal samples. The sample was first defrosted
on ice and a total of 200ul was delivered via the oral and
intra-colonic routes to each mouse. Animals with the same
fecal samples were housed in the same isolator. Food was
autoclaved mouse chow and supplied ad libitum. In pre-
liminary experiments, we determined that 2 weeks post
transplant was sufficient to allow re-constitution of an in-
tact microbiome. For the current study, fecal samples were
taken at 4 weeks. The pellets were processed for DNA and
16S rDNA microbiome analysis is performed. All mice
were bred and maintained and all animal experimentation
was approved in accordance with guidelines and approval
of the University of Alabama at Birmingham Institutional
Animal Care and Use Committee.
Additional files
Additional file 1: Characteristics of donors and patients. (XLSX 12 kb)
Additional file 2: Preparation of the donor sample and
administration. (DOCX 100 kb)
Additional file 3: Relative abundance of microbes at family level
taxonomy. (XLSX 69 kb)
Additional file 4: Alpha and beta diversity metrics. (XLSX 25 kb)
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